Clinical trial
A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type…
NCT00351546 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00351546 |
|---|---|
| Title | A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes |
| Official title | A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Vildagliptin |
| Enrollment | 12 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jul 13, 2006 |
| Last update posted | May 7, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: